These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5828888)

  • 1. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles.
    CUTCHINS EC
    J Immunol; 1962 Jun; 88():788-95. PubMed ID: 13882798
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.
    Klingele M; Hartter HK; Adu F; Ammerlaan W; Ikusika W; Muller CP
    J Med Virol; 2000 Sep; 62(1):91-8. PubMed ID: 10935994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles antibodies in patients with various types of measles infection.
    Thiry L; Dachy A; Lowenthal A
    Arch Gesamte Virusforsch; 1969; 28(3):278-84. PubMed ID: 5386785
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 9. Measles (rubeola) in previously immunized children.
    Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
    Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 14. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 15. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

  • 16. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 17. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
    BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
    J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increase of immunoglobulins G, A, M, D and specific antibodies in a group of children vaccinated against measles by Czechoslovak live vaccine Movivac Sevac].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Hatiarová Z
    Cas Lek Cesk; 1973 Mar; 112(10):297-301. PubMed ID: 4691543
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.